Implications and interchangeability of meningioma biomarkers for clinical trials and clinical practice

Affiliations

• ¹ Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA. david.raleigh@ucsf.edu.
• ² Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA. david.raleigh@ucsf.edu.
• ³ Department of Pathology, University of California San Francisco, San Francisco, CA, USA. david.raleigh@ucsf.edu.
• ⁴ Departments of Radiation Oncology, Neurological Surgery, and Pathology, University of California San Francisco, Helen Diller Family Cancer Research Building 1450 3rd Street, HD481, 94158, San Francisco, CA, USA. david.raleigh@ucsf.edu.
• ⁵ Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA.
• ⁶ Department of Radiation Oncology, Northwestern University, Chicago, IL, USA.
• ⁷ Radiation Oncology, Utah Cancer Specialists, Salt Lake City, UT, USA.
• ⁸ Miami Cancer Institute, Baptist Health, Miami, FL, USA.